ad image

Merck & Co.

1 / 3
Merck & Co.
Vaccine

Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating Pneumococcal Conjugate Vaccine

Merck & Co.

PA1299Sep 11, 2020
TriRx Pharmaceutical Services
M&A

TriRx Pharmaceutical Services Acquires MSD Animal Health Manufacturing Site located in Segre-en Anjou Bleu, France Including Long-term Supply Agreement

TriRx Pharmaceutical Services

PR-M09-20-NI-01Sep 01, 2020
IRBM
Collaboration

Merck and IRBM Announce Pioneering Collaboration to Advance Peptide Therapeutics

IRBM

PR-M07-20-NI-33Jul 23, 2020
Merck & Co.
COVID-19 Vaccine

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

Merck & Co.

PR-M05-20-NI-036May 26, 2020
Merck & Co.
M&A

Merck to Acquire Themis

Merck & Co.

PR-M05-20-NI-035May 26, 2020
Merck & Co.
Emergency Response

Merck to Donate 300,000 Masks to New Jersey for COVID-19 Emergency Response

Merck & Co.

PR-M04-20-NI-008Apr 07, 2020
Eli Lilly and Company

Medical Professionals Across Merck, Pfizer, and Eli Lilly Volunteer Amid COVID-19 Pandemic

Eli Lilly and Company

PR-M04-20-NI-004 Apr 02, 2020
MilliporeSigma
3D Printing

Merck KGaA, Darmstadt, Germany and AMCM / EOS Cooperate in 3D Printing of Tablets

MilliporeSigma

PR-M02-20-NI-042Feb 27, 2020
Merck & Co.
M&A

Merck to Acquire ArQule, Advancing Leadership in Oncology

Merck & Co.

PR-M12-19-NI-017Dec 12, 2019
Merck & Co.
Vaccine Approval

Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union

Merck & Co.

PR-M11-19-NI-011Nov 13, 2019
U.S. FDA Approved New Antibacterial for Urinary Tract and Abdominal Infections
FDA Approval

U.S. FDA Approved New Antibacterial for Urinary Tract and Abdominal Infections

Pharma's Almanac

PAO-M08-19-NI-015Aug 07, 2019
Merck & Co.
Vaccine

CDC Advisory Recommends Vaccination of Adults Ages 27-45 with GARDASIL®9 & Harmonization of Catch-up Vaccination for Males and Females Through Age 26

Merck & Co.

PR-M07-19-NI-004Jul 01, 2019
Merck & Co.
Track and Trace

IBM, KPMG, Merck and Walmart to Collaborate as Part of FDA’s Program to Evaluate the Use of Blockchain to Protect Pharmaceutical Product Integrity

Merck & Co.

PR-M06-19-NI-021Jun 17, 2019
Merck & Co.
M&A

Merck to Acquire Peloton Therapeutics, Bolstering Oncology Pipeline

Merck & Co.

PR-M05-19-NI-067May 23, 2019
Merck Undergoes Restructuring
Restructuring

Merck Undergoes Restructuring

Nice Insight

PAO-M05-19-NI-009May 10, 2019
Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer
Announcement

Merck KGaA, Darmstadt, Germany, and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

MilliporeSigma

PR-M03-19-NI-062Mar 22, 2019
Merck’s Keytruda to Get Accelerated FDA Evaluation for Treatment of Head and Neck Cancer
Accelerated Approval

Merck’s Keytruda to Get Accelerated FDA Evaluation for Treatment of Head and Neck Cancer

Pharma's Almanac

PAO-M02-19-NI-015Feb 19, 2019
U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar
Biosimilars

U.S. Department of Veterans Affairs Signs Contract with Merck for its Remicade Biosimilar

Nice Insight

PAO-M10-18-NI-010Oct 12, 2018
Eisai
FDA Approval

Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)

Eisai

PR-M09-18-NI-070Sep 24, 2018
Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval
FDA Approval

Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M09-18-NI-003Sep 06, 2018
1 / 3